Live Analyst Rating Changes 1505 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Richard Xu
MS
Richard Xu
Morgan Stanley
Wall Street Analyst
★★★☆☆
#1737
on 13Foresight · ranked by our own returns
33%
Success Rate
-25.0%
Average Return
1 of 3 calls profitable · -28.5% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 33% of Richard Xu's ratings turned a profit when each position was held for 1 year — averaging -25.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

23 Buy 1 Hold 0 Sell
Richard's Stock Coverage 17 ratings · 2026-06-18
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
HK:1299
AIA Group
 Jun 10, 2026 BUY Strong Buy
+40.9% avg upside
9 analysts
$109.00
48.00% Upside
 ·
HK:3660
Qfin Holdings
 May 27, 2026 BUY Strong Buy
+37.2% avg upside
2 analysts
$97.50
56.43% Upside
 ·
HK:1288
Agricultural Bank of China
 Apr 08, 2026 BUY Strong Buy
+8.2% avg upside
5 analysts
$6.90
21.76% Upside
 ·
HK:2318
Ping An Insurance Company of China
 Apr 08, 2026 BUY Strong Buy
+38.4% avg upside
10 analysts
$89.00
65.36% Upside
 ·
HK:0388
Hong Kong Exchanges & Clearing
 Feb 26, 2026 BUY Strong Buy
+40.4% avg upside
3 analysts
$508.00
35.61% Upside
 ·
QFIN
Qifu Technology
 Dec 28, 2025 BUY Strong Buy
+112.1% avg upside
8 analysts
$50.00
232.77% Upside
 -16.2%
HK:1398
Industrial and Commercial Bank of China
 Dec 18, 2025 BUY Strong Buy
+6.7% avg upside
5 analysts
$8.00
16.86% Upside
 ·
HK:6608
Bairong, Inc. Class B
 Sep 09, 2025 HOLD Hold
+116.1% avg upside
1 analyst
$11.50
116.14% Upside
 ·
HK:2328
PICC Property & Casualty Co
 Mar 28, 2025 BUY Buy
+5.7% avg upside
7 analysts
$15.10
0.38% Upside
 ·
HK:1336
New China Life Insurance Co., Ltd. Class H
 Sep 23, 2024 SELL Sell
-23.1% avg upside
5 analysts
$15.40
69.04% Downside
 ·
HK:0966
China Taiping Insurance Holdings Co
 Sep 23, 2024 HOLD Strong Buy
-11.8% avg upside
6 analysts
$10.60
45.55% Downside
 ·
HK:2601
China Pacific Insurance (Group) Co
 Sep 23, 2024 BUY Strong Buy
+23.7% avg upside
7 analysts
$29.20
2.47% Upside
 ·
HK:6060
ZhongAn Online P & C Insurance Co., Ltd
 Sep 23, 2024 BUY Strong Buy
+113.9% avg upside
4 analysts
$12.40
22.15% Upside
 ·
LU
Lufax Holding
 Jun 07, 2024 HOLD Sell
+121.4% avg upside
8 analysts
$2.40
77.85% Upside
 +26.6%
HK:1658
Postal Savings Bank of China Co., Ltd. Class H
 Sep 28, 2023 BUY Strong Buy
+19.9% avg upside
5 analysts
$5.60
13.12% Upside
 ·
HK:3968
China Merchants Bank Co
 Jan 14, 2022 BUY Strong Buy
+19.6% avg upside
7 analysts
$84.10
78.32% Upside
 ·
LX
Lexinfintech Holdings
 Jun 14, 2021 BUY Strong Buy
+332.6% avg upside
3 analysts
$18.00
799.99% Upside
 -85.3%
🔒 12 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Richard Xu — Frequently Asked Questions
How accurate are Richard Xu's stock ratings?
Based on the calls 13Foresight could measure, about 33% of Richard's ratings were profitable over a one-year hold, with an average return of -25.0% per rating, or -28.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Richard ranked on 13Foresight?
Richard Xu is currently ranked #1737 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Richard cover?
Richard most recently has ratings on HK:1299, HK:3660, HK:1288, HK:2318, HK:0388, QFIN, HK:1398, HK:6608, HK:2328, HK:1336, HK:0966, HK:2601 and 5 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.